[Acute coronary occlusion during transluminal angioplasty: role of coronary thrombosis]

C Buonanno1

  • 1Servizio di Cardiologia, Ospedale Civile Maggiore, Verona.

Giornale Italiano Di Cardiologia
|June 1, 1988
PubMed

Insights

Transluminal coronary angioplasty complicated by thrombus formation can be successfully managed conservatively. Conservative treatment with thrombolytics, anticoagulants, and platelet inhibitors restored vessel patency in these cases.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Thrombosis

Background:

  • Intracoronary thrombus formation can complicate transluminal coronary angioplasty (TCA).
  • Successful mechanical dilatation may paradoxically activate thrombotic processes, leading to vessel occlusion.

Observation:

  • Two patients undergoing TCA presented with baseline intracoronary thrombus.
  • Mechanical dilatation led to clot proliferation and vessel occlusion in both cases.
  • Intracoronary streptokinase partially slowed but did not inhibit the thrombotic process or restore patency.

Findings:

  • Conservative management with anticoagulants and platelet inhibitors, alongside thrombolytic therapy, resulted in patent coronary arteries at short-term angiography.
  • One patient experienced moderate myocardial enzyme release, while the other did not.

Implications:

  • Acute coronary occlusion during TCA caused by identified thrombus can be managed conservatively with thrombolytic therapy.
  • This approach may obviate the need for emergency coronary surgery, especially if occlusion is short-lived or collateral circulation is adequate.
  • Spontaneous activation of lytic systems can restore vessel patency, potentially preventing myocardial infarction.

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...